HCA Healthcare, Inc. $HCA Stock: Investment House LLC Lowers Position

Key Points

• Investment House LLC cut its HCA Healthcare position by 47.1% in the third quarter, selling 4,259 shares and retaining 4,789 shares valued at approximately $2.04 million. Institutional investors and hedge funds collectively own 62.73% of the company.
• HCA shares were trading at $467, up 1.7%, with a market capitalization of about $101.1 billion. The company exceeded quarterly expectations with earnings of $7.59 per share and revenue of $20.23 billion, while revenue increased 8.7% year over year.
• Analyst sentiment remains positive overall, with 16 Buy, seven Hold and one Sell rating, producing a “Moderate Buy” consensus and an average price target of $467.61. However, several firms recently lowered their targets, and higher operating costs and legal uncertainty present risks.

Investment House LLC trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 47.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,789 shares of the company's stock after selling 4,259 shares during the period. Investment House LLC's holdings in HCA Healthcare were worth $2,044,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. boosted its position in HCA Healthcare by 24.7% in the 3rd quarter. SBI Securities Co. Ltd. now owns 111 shares of the company's stock worth $47,000 after purchasing an additional 22 shares in the last quarter. Piedmont Capital Management LLC NC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $208,000. Axxcess Wealth Management LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at about $231,000. Quadrant Capital Group LLC boosted its holdings in HCA Healthcare by 3.1% in the 3rd quarter. Quadrant Capital Group LLC now owns 6,324 shares of the company's stock worth $2,914,000 after buying an additional 191 shares during the last quarter. Finally, Robbins Farley increased its stake in HCA Healthcare by 23.5% during the 3rd quarter. Robbins Farley now owns 5,393 shares of the company's stock worth $2,301,000 after buying an additional 1,025 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 1.7%

Shares of NYSE:HCA opened at $467.00 on Friday. The company has a market cap of $101.11 billion, a P/E ratio of 15.46, a P/E/G ratio of 1.55 and a beta of 1.10. The business has a fifty day simple moving average of $430.28 and a 200-day simple moving average of $418.61. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $6.84 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 29.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent research reports. Robert W. Baird cut their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a report on Monday, July 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a report on Friday, October 2nd. Oppenheimer lowered their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating on the stock in a research report on Monday, July 27th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research note on Monday, July 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $467.61.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is benefiting from a broader defensive rotation in which investors are emphasizing company quality and earnings resilience over traditional sector classifications. Defensive rotation: Quality over sector labels in healthcare, banks, and consumer staples
• Positive Sentiment: TD Cowen raised its price target for HCA to $460, signaling continued confidence in the hospital operator’s outlook and valuation. TD Cowen lifts target to USD 460
• Positive Sentiment: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term expansion, market presence and future capacity in Florida. Cape Coral approves $31M in incentives for $300M HCA hospital
• Positive Sentiment: Analysts expect third-quarter results to benefit from higher admissions, occupancy and inpatient revenue. Investors are focused on whether these trends can support earnings ahead of HCA’s scheduled earnings call. Will HCA Healthcare’s Q3 Earnings Benefit From Higher Admissions?
• Neutral Sentiment: HCA opened a clinical training center in Gainesville, which could strengthen workforce development and staffing over time but is unlikely to materially affect near-term earnings. HCA Healthcare opens clinical training center in Gainesville
• Negative Sentiment: Higher operating costs and fewer outpatient surgeries could offset the benefit of stronger admissions, making the third-quarter earnings outlook mixed. Will HCA Healthcare’s Q3 Earnings Benefit From Higher Admissions?
• Negative Sentiment: HCA is disputing a state’s authority to enforce terms related to its Mission Health acquisition, creating potential legal, financial and reputational uncertainty. HCA disputes state’s authority to enforce purchase agreement

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.